Both events highlight the strength of the Pharmaceutical Management Program and Rutgers Business School's close ties to the industry.
New Jersey, once known as the nation's medicine chest because of its large concentration of drug-making companies, continues to be a hub for the pharmaceutical and biotechnology industries.
Rutgers Business School's nine-year-old Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues has strengthened the school's ties to some of the world's leading drug and device companies through symposiums, joint research and education programs designed to develop the next generation of leaders in the industry.
Mahmud Hassan, director of the Blanche and Irwin Lerner Center for the Study of Pharmaceutical Management Issues, said one of the biggest attractions for students at the case competitions is the potential to network.
While well-established case competitions at Kellogg, Wake Forest and Louisville are sponsored by one pharmaceutical company, Rutgers has sponsorship from eight – Bayer, Janssen, Novartis, Novo Nordisk, Bristol-Myers Squibb, Eisai, Campbell Alliance and Herspiegel Consulting.
"That's a unique opportunity for students," Hassan said.
Merck, which has its world headquarters in New Jersey, identified a number of students during the case competition at Rutgers last year and ended up hiring some of them, he said.
That sort of opportunity also explains why some of the schools were so eager to participate.
Bitar said some of the teams had identified the Rutgers case competition as one they wanted to attend even before the official invitations went out. "It's a sign that we did a good job the first time around," she said.
For Bitar and Schnipper, it's also proof that
|SOURCE Rutgers Business School|
Copyright©2012 PR Newswire.
All rights reserved